|
1
|
Virani SS, Alonso A, Benjamin EJ,
Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR,
Cheng S, Delling FN, et al: Heart Disease and Stroke
Statistics-2020 Update: A Report From the American Heart
Association. Circulation. 141:e139–e596. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Roth GA, Mensah GA, Johnson CO, Addolorato
G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ,
Benziger CP, et al: Global Burden of Cardiovascular Diseases and
Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll
Cardiol. 76:2982–3021. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Del Re DP, Amgalan D, Linkermann A, Liu Q
and Kitsis RN: Fundamental Mechanisms of Regulated Cell Death and
Implications for Heart Disease. Physiol Rev. 99:1765–1817. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Reis AH: From Assessing Risk Factors to
Understanding, Preventing, and Treating Cardiovascular Diseases: An
urgent journey. Discov Med. 34:199–204. 2022.
|
|
5
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell
Death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gao M, Yi J, Zhu J, Minikes AM, Monian P,
Thompson CB and Jiang X: Role of Mitochondria in Ferroptosis. Mol
Cell. 73:354–363.e3. 2019. View Article : Google Scholar :
|
|
7
|
Powell LW, Seckington RC and Deugnier Y:
Haemochromatosis. Lancet. 388:706–716. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Park E and Chung SW: ROS-mediated
autophagy increases intracellular iron levels and ferroptosis by
ferritin and transferrin receptor regulation. Cell Death Dis.
10:8222019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Song Y, Wang B, Zhu X, Hu J, Sun J, Xuan J
and Ge Z: Human umbilical cord blood-derived MSCs exosome attenuate
myocardial injury by inhibiting ferroptosis in acute myocardial
infarction mice. Cell Biol Toxicol. 37:51–64. 2021. View Article : Google Scholar
|
|
10
|
Li W, Li W, Leng Y, Xiong Y and Xia Z:
Ferroptosis is involved in diabetes myocardial ischemia/reperfusion
injury through endoplasmic reticulum stress. DNA Cell Biol.
39:210–225. 2020. View Article : Google Scholar
|
|
11
|
Gaschler MM and Stockwell BR: Lipid
peroxidation in cell death. Biochem Biophys Res Commun.
482:419–425. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Stockwell BR, Friedmann Angeli JP, Bayir
H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascón S, Hatzios SK,
Kagan VE, et al: Ferroptosis: A Regulated Cell Death Nexus Linking
Metabolism, Redox Biology, and Disease. Cell. 171:273–285. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stoyanovsky DA, Tyurina YY, Shrivastava I,
Bahar I, Tyurin VA, Protchenko O, Jadhav S, Bolevich SB, Kozlov AV,
Vladimirov YA, et al: Iron catalysis of lipid peroxidation in
ferroptosis: Regulated enzymatic or random free radical reaction?
Free Radic Biol Med. 133:153–161. 2019. View Article : Google Scholar :
|
|
14
|
Lin Z, Liu J, Kang R, Yang M and Tang D:
Lipid Metabolism in Ferroptosis. Adv Biol (Weinh). 5:e21003962021.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Conrad M and Pratt DA: The chemical basis
of ferroptosis. Nat Chem Biol. 15:1137–1147. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Naoe S, Tsugawa H, Takahashi M, Ikeda K
and Arita M: Characterization of lipid profiles after dietary
intake of polyunsaturated fatty acids using integrated untargeted
and targeted lipidomics. Metabolites. 9:2412019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kagan VE, Mao G, Qu F, Angeli JP, Doll S,
Croix CS, Dar HH, Liu B, Tyurin VA, Ritov VB, et al: Oxidized
arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem
Biol. 13:81–90. 2017. View Article : Google Scholar
|
|
18
|
Doll S, Proneth B, Tyurina YY, Panzilius
E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A,
et al: ACSL4 dictates ferroptosis sensitivity by shaping cellular
lipid composition. Nat Chem Biol. 13:91–98. 2017. View Article : Google Scholar :
|
|
19
|
Li Y, Feng D, Wang Z, Zhao Y, Sun R, Tian
D, Liu D, Zhang F, Ning S, Yao J and Tian X: Ischemia-induced ACSL4
activation contributes to ferroptosis-mediated tissue injury in
intestinal ischemia/reperfusion. Cell Death Differ. 26:2284–2299.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Orafaie A, Mousavian M, Orafai H and
Sadeghian H: An overview of lipoxygenase inhibitors with approach
of in vivo studies. Prostaglandins Other Lipid Mediat.
148:1064112020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Smith LM, Aitken HM and Coote ML: The Fate
of the Peroxyl Radical in Autoxidation: How does polymer
degradation really occur? Acc Chem Res. 51:2006–2013. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ilari S, Giancotti LA, Lauro F, Gliozzi M,
Malafoglia V, Palma E, Tafani M, Russo MA, Tomino C, Fini M, et al:
Natural antioxidant control of neuropathic pain-exploring the role
of mitochondrial SIRT3 pathway. Antioxidants (Basel). 9:11032020.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fan X, Li A, Yan Z, Geng X, Lian L, Lv H,
Gao D and Zhang J: From iron metabolism to ferroptosis: Pathologic
changes in coronary heart disease. Oxid Med Cell Longev.
2022:62918892022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hu H, Chen Y, Jing L, Zhai C and Shen L:
The Link Between Ferroptosis and Cardiovascular Diseases: A novel
target for treatment. Front Cardiovasc Med. 8:7109632021.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen Z, Yan Y, Qi C, Liu J, Li L and Wang
J: The Role of Ferroptosis in Cardiovascular Disease and Its
Therapeutic Significance. Front Cardiovasc Med. 8:7332292021.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Y, Xin L, Xiang M, Shang C, Wang Y,
Wang Y, Cui X and Lu Y: The molecular mechanisms of ferroptosis and
its role in cardiovascular disease. Biomed Pharmacother.
145:1124232022. View Article : Google Scholar
|
|
27
|
Yu Y, Jiang L, Wang H, Shen Z, Cheng Q,
Zhang P, Wang J, Wu Q, Fang X, Duan L, et al: Hepatic transferrin
plays a role in systemic iron homeostasis and liver ferroptosis.
Blood. 136:726–739. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mancias JD, Wang X, Gygi SP, Harper JW and
Kimmelman AC: Quantitative proteomics identifies NCOA4 as the cargo
receptor mediating ferritinophagy. Nature. 509:105–109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fang X, Ardehali H, Min J and Wang F: The
molecular and metabolic landscape of iron and ferroptosis in
cardiovascular disease. Nat Rev Cardiol. 20:7–23. 2023. View Article : Google Scholar
|
|
30
|
Yuan H, Li X, Zhang X, Kang R and Tang D:
CISD1 inhibits ferroptosis by protection against mitochondrial
lipid peroxidation. Biochem Biophys Res Commun. 478:838–844. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim EH, Shin D, Lee J, Jung AR and Roh JL:
CISD2 inhibition overcomes resistance to sulfasalazine-induced
ferroptotic cell death in head and neck cancer. Cancer Lett.
432:180–190. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sies H: Glutathione and its role in
cellular functions. Free Radic Biol Med. 27:916–921. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu G, Fang YZ, Yang S, Lupton JR and
Turner ND: Glutathione Metabolism and Its Implications for Health.
J Nutr. 134:489–492. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pompella A, Visvikis A, Paolicchi A, Tata
VD and Casini AF: The changing faces of glutathione, a cellular
protagonist. Biochem Pharmacol. 66:1499–1503. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Paul BD, Sbodio JI and Snyder SH: Cysteine
Metabolism in Neuronal Redox Homeostasis. Trends Pharmacol Sci.
39:513–524. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ursini F and Maiorino M: Lipid
peroxidation and ferroptosis: The role of GSH and GPx4. Free Radic
Biol Med. 152:175–185. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Desideri E, Ciccarone F and Ciriolo MR:
Targeting glutathione metabolism: Partner in crime in anticancer
therapy. Nutrients. 11:19262019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang Y, Zhao Y, Wang H, Zhang C, Wang M,
Yang Y, Xu X and Hu Z: Histone demethylase KDM3B protects against
ferroptosis by upregulating SLC7A11. FEBS Open Bio. 10:637–643.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu J, Zhang C, Hu W and Feng Z: Tumor
suppressor p53 and metabolism. J Mol Cell Biol. 11:284–292. 2019.
View Article : Google Scholar :
|
|
40
|
Kastenhuber ER and Lowe SW: Putting p53 in
Context. Cell. 170:1062–1078. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zille M, Karuppagounder SS, Chen Y, Gough
PJ, Bertin J, Finger J, Milner TA, Jonas EA and Ratan RR: Neuronal
death after hemorrhagic stroke in vitro and in vivo shares features
of ferroptosis and necroptosis. Stroke. 48:1033–1043. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R
and Tang D: Activation of the p62-Keap1-NRF2 pathway protects
against ferroptosis in hepatocellular carcinoma cells. Hepatology.
63:173–184. 2016. View Article : Google Scholar
|
|
43
|
Dodson M, Castro-Portuguez R and Zhang DD:
NRF2 plays a critical role in mitigating lipid peroxidation and
ferroptosis. Redox Biol. 23:1011072019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kang R, Kroemer G and Tang D: The tumor
suppressor protein p53 and the ferroptosis network. Free Radic Biol
Med. 133:162–168. 2019. View Article : Google Scholar
|
|
45
|
Lipper CH, Stofleth JT, Bai F, Sohn YS,
Roy S, Mittler R, Nechushtai R, Onuchic JN and Jennings PA:
Redox-dependent gating of VDAC by mitoNEET. Proc Natl Acad Sci USA.
116:19924–19929. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Rostovtseva TK, Tan W and Colombini M: On
the Role of VDAC in Apoptosis: Fact and Fiction. J Bioenerg
Biomembr. 37:129–142. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Fang D and Maldonado EN: VDAC regulation:
A mitochondrial target to stop cell proliferation. Adv Cancer Res.
138:41–69. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Mazure NM: VDAC in cancer. Biochim Biophys
Acta Bioenerg. 1858:665–673. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lemasters JJ: Evolution of
Voltage-Dependent Anion Channel Function: From molecular sieve to
governator to actuator of ferroptosis. Front Oncol. 7:3032017.
View Article : Google Scholar
|
|
50
|
Yagoda N, von Rechenberg M, Zaganjor E,
Bauer AJ, Yang WS, Fridman DJ, Wolpaw AJ, Smukste I, Peltier JM,
Boniface JJ, et al: RAS-RAF-MEK-dependent oxidative cell death
involving voltage-dependent anion channels. Nature. 447:865–868.
2007. View Article : Google Scholar
|
|
51
|
DeHart DN, Fang D, Heslop K, Li L,
Lemasters JJ and Maldonado EN: Opening of voltage dependent anion
channels promotes reactive oxygen species generation, mitochondrial
dysfunction and cell death in cancer cells. Biochem Pharmacol.
148:155–162. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Iurlaro R and Muñoz-Pinedo C: Cell death
induced by endoplasmic reticulum stress. FEBS J. 283:2640–2652.
2016. View Article : Google Scholar
|
|
53
|
Dixon SJ, Patel DN, Welsch M, Skouta R,
Lee ED, Hayano M, Thomas AG, Gleason CE, Tatonetti NP, Slusher BS
and Stockwell BR: Pharmacological inhibition of cystine-glutamate
exchange induces endoplasmic reticulum stress and ferroptosis.
Elife. 3:e025232014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Chen Y, Mi Y, Zhang X, Ma Q, Song Y, Zhang
L, Wang D, Xing J, Hou B, Li H, et al: Dihydroartemisinin-induced
unfolded protein response feedback attenuates ferroptosis via
PERK/ATF4/HSPA5 pathway in glioma cells. J Exp Clin Cancer Res.
38:4022019. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Luo Y, Guo Q, Zhang L, Zhuan Q, Meng L, Fu
X and Hou Y: Dihydroartemisinin exposure impairs porcine ovarian
granulosa cells by activating PERK-eIF2α-ATF4 through endoplasmic
reticulum stress. Toxicol Appl Pharmacol. 403:1151592020.
View Article : Google Scholar
|
|
56
|
Rozpedek W, Pytel D, Mucha B, Leszczynska
H, Diehl JA and Majsterek I: The Role of the PERK/eIF2α/ATF4/CHOP
Signaling Pathway in Tumor Progression During Endoplasmic Reticulum
Stress. Curr Mol Med. 16:533–544. 2016. View Article : Google Scholar
|
|
57
|
Yan L, Luo H, Li X and Li Y: d-Pinitol
protects against endoplasmic reticulum stress and apoptosis in
hepatic ischemia-reperfusion injury via modulation of
AFT4-CHOP/GRP78 and caspase-3 signaling pathways. Int J
Immunopathol Pharmacol. 35:1–15. 2021. View Article : Google Scholar
|
|
58
|
Chen Y, Mi Y and Zhang X: The CoQ
oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. J
Cell Physiol. 575:688–692. 2019.
|
|
59
|
Doll S, Freitas FP, Shah R, Aldrovandi M,
da Silva MC, Ingold I, Goya Grocin A, Xavier da Silva TN, Panzilius
E, Scheel CH, et al: FSP1 is a glutathione-independent ferroptosis
suppressor. Nature. 575:693–698. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Shimada K, Skouta R, Kaplan A, Yang WS,
Hayano M, Dixon SJ, Brown LM, Valenzuela CA, Wolpaw AJ and
Stockwell BR: Global survey of cell death mechanisms reveals
metabolic regulation of ferroptosis. Nat Chem Biol. 12:497–503.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Miriyala S, Thippakorn C, Chaiswing L, Xu
Y, Noel T, Tovmasyan A, Batinic-Haberle I, Vander Kooi CW, Chi W,
Latif AA, et al: Novel role of 4-hydroxy-2-nonenal in
AIFm2-mediated mitochondrial stress signaling. Free Radic Biol Med.
91:68–80. 2016. View Article : Google Scholar :
|
|
62
|
Martinet W, Coornaert I, Puylaert P and De
Meyer GRY: Macrophage death as a pharmacological target in
atherosclerosis. Front Pharmacol. 10:3062019. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Xiao L, Luo G, Guo X, Jiang C, Zeng H,
Zhou F, Li Y, Yu J and Yao P: Macrophage iron retention aggravates
atherosclerosis: Evidence for the role of autocrine formation of
hepcidin in plaque macrophages. Biochim Biophys Acta Mol Cell Biol
Lipids. 1865:1585312020. View Article : Google Scholar
|
|
64
|
Kiechl S, Willeit J, Egger G, Poewe W and
Oberhollenzer F: Body Iron Stores and the Risk of Carotid
Atherosclerosis: Prospective results from the Bruneck study.
Circulation. 96:3300–3307. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Hou JW: Iron-load exacerbates the severity
of atherosclerosis via inducing inflammation and enhancing the
glycolysis in macrophages. Nutrition. 38:329–334. 2002.
|
|
66
|
Luo EF, Li HX, Qin YH, Qiao Y, Yan GL, Yao
YY, Li LQ, Hou JT, Tang CC and Wang D: Role of ferroptosis in the
process of diabetes-induced endothelial dysfunction. World J
Diabetes. 12:124–137. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Park TJ, Park JH, Lee GS, Lee JY, Shin JH,
Kim MW, Kim YS, Kim JY, Oh KJ, Han BS, et al: Quantitative
proteomic analyses reveal that GPX4 downregulation during
myocardial infarction contributes to ferroptosis in cardiomyocytes.
Cell Death Dis. 10:8352019. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Baba Y, Higa JK, Shimada BK, Horiuchi KM,
Suhara T, Kobayashi M, Woo JD, Aoyagi H, Marh KS, Kitaoka H, et al:
Protective effects of the mechanistic target of rapamycin against
excess iron and ferroptosis in cardiomyocytes. Am J Physiol Heart
Circ Physiol. 314:H659–H668. 2018. View Article : Google Scholar :
|
|
69
|
Zhang T, Zhang Y, Cui M, Jin L, Wang Y, Lv
F, Liu Y, Zheng W, Shang H, Zhang J, et al: CaMKII is a RIP3
substrate mediating ischemia- and oxidative stress-induced
myocardial necroptosis. Nat Med. 22:175–182. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Farmer EE and Mueller MJ: ROS-Mediated
Lipid Peroxidation and RES-Activated Signaling. Annu Rev Plant
Biol. 64:429–450. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Scindia Y PhD, Leeds J MD and Swaminathan
S MD: Iron homeostasis in healthy kidney and its role in acute
kidney injury. Semin Nephrol. 39:76–84. 2019. View Article : Google Scholar
|
|
72
|
Gao M, Monian P, Quadri N, Ramasamy R and
Jiang X: Glutaminolysis and transferrin regulate ferroptosis. Mol
Cell. 59:298–308. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Fang X, Wang H, Han D, Xie E, Yang X, Wei
J, Gu S, Gao F, Zhu N, Yin X, et al: Ferroptosis as a target for
protection against cardiomyopathy. Proc Natl Acad Sci USA.
116:2672–2680. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Tang LJ, Luo XJ, Tu H, Chen H, Xiong XM,
Li NS and Peng J: Ferroptosis occurs in phase of reperfusion but
not ischemia in rat heart following ischemia or
ischemia/reperfusion. Naunyn Schmiedebergs Arch Pharmacol.
394:401–410. 2021. View Article : Google Scholar
|
|
75
|
Hess ML and Manson NH: Molecular oxygen:
Friend and foe*The role of the oxygen free radical system in the
calcium paradox, the oxygen paradox and ischemia/reperfusion
injury. J Mol Cell Cardiol. 37:969–985. 1984. View Article : Google Scholar
|
|
76
|
Ghosh AP, Klocke BJ, Ballestas ME and Roth
KA: CHOP Potentially Co-Operates with FOXO3a in Neuronal Cells to
Regulate PUMA and BIM Expression in Response to ER Stress. PLoS
One. 7:e395862012. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Lee YS, Lee DH, Choudry HA, Bartlett DL
and Lee YJ: Ferroptosis-Induced Endoplasmic Reticulum Stress:
Cross-talk between Ferroptosis and Apoptosis. Mol Cancer Res.
16:1073–1076. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Sampilvanjil A, Karasawa T and Yamada N:
Endoplasmic Reticulum Stress and oxidative stress in cell fate
decision and human disease. Proc Natl Acad Sci USA. 160:303–318.
2020.
|
|
79
|
Elliott P, Andersson B, Arbustini E,
Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B,
McKenna WJ, et al: Classification of the cardiomyopathies: A
position statement from the European Society Of Cardiology Working
Group On Myocardial And Pericardial Diseases. Eur Heart J.
29:270–276. 2008. View Article : Google Scholar
|
|
80
|
Hashimoto H, Olson EN and Bassel-Duby R:
Therapeutic approaches for cardiac regeneration and repair. Nat Rev
Cardiol. 15:585–600. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Young RC, Ozols RF and Myers CE: The
anthracycline antineoplastic drugs. N Engl J Med. 305:139–153.
1981. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Singal PK and Iliskovic N:
Doxorubicin-induced cardiomyopathy. N Engl J Med. 339:900–905.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Tadokoro T, Ikeda M and Ide T:
Mitochondrial outer membrane protein FUNDC2 promotes ferroptosis
and contributes to doxorubicin-induced cardiomyopathy. Am J Physiol
Heart Circ Physiol. 119:e21173961192022.
|
|
84
|
Sun X, Sun P, Zhen D, Xu X, Yang L, Fu D,
Wei C, Niu X, Tian J and Li H: Melatonin alleviates
doxorubicin-induced mitochondrial oxidative damage and ferroptosis
in cardiomyocytes by regulating YAP expression. Toxicol Appl
Pharmacol. 437:1159022022. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Wang Y, Yan S, Liu X, Deng F, Wang P, Yang
L, Hu L, Huang K and He J: PRMT4 promotes ferroptosis to aggravate
doxorubicin-induced cardiomyopathy via inhibition of the Nrf2/GPX4
pathway. Cell Death Differ. 29:1982–1995. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Zhuang S, Ma Y, Zeng Y, Lu C, Yang F,
Jiang N, Ge J, Ju H, Zhong C, Wang J, et al: METTL14 promotes
doxorubicin-induced cardiomyocyte ferroptosis by regulating the
KCNQ1OT1-miR-7-5p-TFRC axis. Cell Biol Toxicol. 39:1015–1035. 2023.
View Article : Google Scholar
|
|
87
|
Wang B, Wang H, Zhang M, Ji R, Wei J, Xin
Y and Jiang X: Radiation-induced myocardial fibrosis: Mechanisms
underlying its pathogenesis and therapeutic strategies. J Cell Mol
Med. 24:7717–7729. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Wang H, Wei J, Zheng Q, Meng L, Xin Y, Yin
X and Jiang X: Radiation-induced heart disease: A review of
classification, mechanism and prevention. Int J Biol Sci.
15:2128–2138. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Kuwahara Y, Oikawa T, Ochiai Y, Roudkenar
MH and Fukumoto M, Shimura T, Ohtake Y, Ohkubo Y, Mori S, Uchiyama
Y and Fukumoto M: Enhancement of autophagy is a potential modality
for tumors refractory to radiotherapy. Cell Death Dis. 2:e1772011.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Jelonek K, Walaszczyk A, Gabryś D,
Pietrowska M, Kanthou C and Widłak P: Cardiac endothelial cells
isolated from mouse heart-a novel model for radiobiology. Acta
Biochim Pol. 58:397–404. 2011. View Article : Google Scholar
|
|
91
|
Taunk NK, Haffty BG, Kostis JB and Goyal
S: Radiation-Induced Heart Disease: Pathologic Abnormalities and
Putative Mechanisms. Front Oncol. 5:392015. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Klein D, Steens J, Wiesemann A, Schulz F,
Kaschani F, Röck K, Yamaguchi M, Wirsdörfer F, Kaiser M, Fischer
JW, et al: Mesenchymal stem cell therapy protects lungs from
radiation-induced endothelial cell loss by restoring superoxide
dismutase 1 expression. Antioxid Redox Signal. 26:563–582. 2017.
View Article : Google Scholar :
|
|
93
|
Liao JK: Linking endothelial dysfunction
with endothelial cell activation. Front Oncol. 123:540–541.
2013.
|
|
94
|
Van Der Meeren A, Squiban C, Gourmelon P,
Lafont H and Gaugler MH: Differential regulation by IL-4 and IL-10
of radiation-induced IL-6 AND IL-8 production and ICAM-1 expression
by human endothelial cells. Cytokine. 11:831–838. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Baselet B, Belmans N, Coninx E, Lowe D,
Janssen A, Michaux A, Tabury K, Raj K, Quintens R, Benotmane MA, et
al: Functional gene analysis reveals cell cycle changes and
inflammation in endothelial cells irradiated with a single X-ray
dose. Front Pharmacol. 8:2132017. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Mortezaee K, Goradel NH, Amini P, Shabeeb
D, Musa AE, Najafi M and Farhood B: NADPH oxidase as a target for
modulation of radiation response; Implications to carcinogenesis
and radiotherapy. Curr Mol Pharmacol. 12:50–60. 2019. View Article : Google Scholar
|
|
97
|
Lei G, Zhang Y, Koppula P, Liu X, Zhang J,
Lin SH, Ajani JA, Xiao Q, Liao Z, Wang H and Gan B: The role of
ferroptosis in ionizing radiation-induced cell death and tumor
suppression. Cell Res. 30:146–162. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Dixon SJ, Winter GE, Musavi LS, Lee ED,
Snijder B, Rebsamen M, Superti-Furga G and Stockwell BR: Human
haploid cell genetics reveals roles for lipid metabolism genes in
nonapoptotic cell death. ACS Chem Biol. 10:1604–1609. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Philipp J, Le Gleut R, Toerne CV, Subedi
P, Azimzadeh O, Atkinson MJ and Tapio S: Radiation response of
human cardiac endothelial cells reveals a central role of the
cGAS-STING pathway in the development of inflammation. Proteomes.
8:302020. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Heidenreich PA, Hancock SL, Lee BK,
Mariscal CS and Schnittger I: Asymptomatic cardiac disease
following mediastinal irradiation. J Am Coll Cardiol. 42:743–749.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Gong CW, Yuan MM, Qiu BQ, Wang LJ, Zou HX,
Hu T, Lai SQ and Liu JC: Identification and Validation of
Ferroptosis-Related Biomarkers in Septic Cardiomyopathy via
Bioinformatics Analysis. Front Genet. 13:8275592022. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Kong C, Ni X, Wang Y, Zhang A, Zhang Y,
Lin F, Li S, Lv Y, Zhu J, Yao X, et al: ICA69 aggravates
ferroptosis causing septic cardiac dysfunction via STING
trafficking. Cell Death Discov. 8:1872022. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Raman B, Bluemke DA, Lüscher TF and
Neubauer S: Long COVID: Post-acute sequelae of COVID-19 with a
cardiovascular focus. Eur Heart J. 43:1157–1172. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Xie Y, Xu E, Bowe B and Al-Aly Z:
Long-term cardiovascular outcomes of COVID-19. Nat Med. 28:583–590.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Katsoularis I, Fonseca-Rodríguez O,
Farrington P, Lindmark K and Fors Connolly AM: Risk of acute
myocardial infarction and ischaemic stroke following COVID-19 in
Sweden: A self-controlled case series and matched cohort study.
Lancet. 398:599–607. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Xie Y, Bowe B, Maddukuri G and Al-Aly Z:
Comparative evaluation of clinical manifestations and risk of death
in patients admitted to hospital with covid-19 and seasonal
influenza: Cohort study. BMJ. 371:m46772020. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Merad M, Blish CA, Sallusto F and Iwasaki
A: The immunology and immunopathology of COVID-19. Science.
375:1122–1127. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Wang Y, Huang J, Sun Y, Stubbs D, He J, Li
W, Wang F, Liu Z, Ruzicka JA, Taylor EW, et al: SARS-CoV-2
suppresses mRNA expression of selenoproteins associated with
ferroptosis, endoplasmic reticulum stress and DNA synthesis. Food
Chem Toxicol. 153:1122862021. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Liu L, Du J, Yang S, Zheng B, Shen J,
Huang J, Cao L, Huang S, Liu X, Guo L, et al: SARS-CoV-2 ORF3a
sensitizes cells to ferroptosis via Keap1-NRF2 axis. Redox Biol.
63:1027522023. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Bai T, Li M and Liu Y: Acyl-coenzyme a
synthetase long-chain family member 4 is involved in viral
replication organelle formation and facilitates virus replication
via ferroptosis. Free Radic Biol Med. 63:194–209. 2020.
|
|
111
|
Han Y, Zhu J, Yang L, Nilsson-Payant BE,
Hurtado R, Lacko LA, Sun X, Gade AR, Higgins CA, Sisso WJ, et al:
SARS-CoV-2 infection induces ferroptosis of sinoatrial node
pacemaker cells. Circ Res. 130:963–977. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Habib HM, Ibrahim S, Zaim A and Ibrahim
WH: The role of iron in the pathogenesis of COVID-19 and possible
treatment with lactoferrin and other iron chelators. Biomed
Pharmacother. 136:1112282021. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Jia G, DeMarco VG and Sowers JR: Insulin
resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat
Rev Endocrinol. 12:144–153. 2016. View Article : Google Scholar :
|
|
114
|
Ritchie RH and Abel ED: Basic mechanisms
of diabetic heart disease. Circ Res. 126:1501–1525. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Liu C, Sun W, Zhu T, Shi S, Zhang J, Wang
J, Gao F, Ou Q, Jin C, Li J, et al: Glia maturation factor-β
induces ferroptosis by impairing chaperone-mediated autophagic
degradation of ACSL4 in early diabetic retinopathy. Redox Biol.
52:1022922022. View Article : Google Scholar
|
|
116
|
Chen L, Yin Z, Qin X, Zhu X, Chen X, Ding
G, Sun D, Wu NN, Fei J, Bi Y, et al: CD74 ablation rescues type 2
diabetes mellitus-induced cardiac remodeling and contractile
dysfunction through pyroptosis-evoked regulation of ferroptosis.
Pharmacol Res. 176:1060862022. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Wei Z, Shaohuan Q, Pinfang K and Chao S:
Curcumin attenuates ferroptosis-induced myocardial injury in
diabetic cardiomyopathy through the Nrf2 pathway. Cardiovasc Ther.
2022:31597172022. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Kwon MY, Park E, Lee SJ and Chung SW: Heme
oxygenase-1 accelerates erastin-induced ferroptotic cell death.
Oncotarget. 6:24393–24403. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Chang LC, Chiang SK, Chen SE, Yu YL, Chou
RH and Chang WC: Heme oxygenase-1 mediates BAY 11-7085 induced
ferroptosis. Cancer Lett. 416:124–137. 2018. View Article : Google Scholar
|
|
120
|
Wang X, Chen X, Zhou W, Men H, Bao T, Sun
Y, Wang Q, Tan Y, Keller BB, Tong Q, et al: Ferroptosis is
essential for diabetic cardiomyopathy and is prevented by
sulforaphane via AMPK/NRF2 pathways. Acta Pharm Sin B. 12:708–722.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Zhang Z, Tang J, Song J, Xie M, Liu Y,
Dong Z, Liu X, Li X, Zhang M, Chen Y, et al: Elabela alleviates
ferroptosis, myocardial remodeling, fibrosis and heart dysfunction
in hypertensive mice by modulating the IL-6/STAT3/GPX4 signaling.
Free Radic Biol Med. 181:130–142. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Menon AV, Liu J, Tsai HP, Zeng L, Yang S,
Asnani A and Kim J: Excess heme upregulates heme oxygenase 1 and
promotes cardiac ferroptosis in mice with sickle cell disease.
Blood. 139:936–941. 2022. View Article : Google Scholar :
|
|
123
|
Rozwadowska K, Raczak G, Sikorska K,
Fijałkowski M, Kozłowski D and Daniłowicz-Szymanowicz L: Influence
of hereditary haemochromatosis on left ventricular wall thickness:
Does iron overload exacerbate cardiac hypertrophy? Folia Morphol
(Warsz). 78:746–753. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Sukumaran A, Chang J, Han M, Mintri S,
Khaw BA and Kim J: Iron overload exacerbates age-associated cardiac
hypertrophy in a mouse model of hemochromatosis. Sci Rep.
7:57562017. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Fang X, Cai Z, Wang H, Han D, Cheng Q,
Zhang P, Gao F, Yu Y, Song Z, Wu Q, et al: Loss of Cardiac Ferritin
H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis. Circ
Res. 127:486–501. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Zhang X, Zheng C, Gao Z, Chen H, Li K,
Wang L, Zheng Y, Li C, Zhang H, Gong M, et al: SLC7A11/xCT prevents
cardiac hypertrophy by inhibiting ferroptosis. Cardiovasc Drugs
Ther. 36:437–447. 2022. View Article : Google Scholar
|
|
127
|
Papayannopoulos V: Methylation-dependent
transcriptional repression of RUNX3 by KCNQ1OT1 regulates mouse
cardiac microvascular endothelial cell viability and inflammatory
response following myocardial infarction. Exp Mol Med. 53:401–426.
2019.
|
|
128
|
Shi P, Song C, Qi H, Ren J, Ren P, Wu J,
Xie Y, Zhang M, Sun H and Cao Y: Up-regulation of IRF3 is required
for docosahexaenoic acid suppressing ferroptosis of cardiac
microvascular endothelial cells in cardiac hypertrophy rat. J Nutr
Biochem. 104:1089722022. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Tang M, Huang Z, Luo X, Liu M, Wang L, Qi
Z, Huang S, Zhong J, Chen JX, Li L, et al: Ferritinophagy
activation and sideroflexin1-dependent mitochondria iron overload
is involved in apelin-13-induced cardiomyocytes hypertrophy. Free
Radical Biol Med. 134:445–457. 2019. View Article : Google Scholar
|
|
130
|
Chen X, Xu S, Zhao C and Liu B: Role of
TLR4/NADPH oxidase 4 pathway in promoting cell death through
autophagy and ferroptosis during heart failure. Biochem Biophys Res
Commun. 516:37–43. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Bertoli SR, Marques VB, Rossi EM, Krause
M, Carneiro MTWD, Simões MR and Dos Santos L: Chronic iron overload
induces vascular dysfunction in resistance pulmonary arteries
associated with right ventricular remodeling in rats. Toxicol Lett.
295:296–306. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Ciarambino T, Menna G, Sansone G and
Giordano M: Cardiomyopathies: An overview. Int J Mol Sci.
22:77222021. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Reichart D, Magnussen C, Zeller T and
Blankenberg S: Dilated cardiomyopathy: From epidemiologic to
genetic phenotypes. J Intern Med. 286:362–372. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Eldemire R, Mestroni L and Taylor MRG:
Genetics of Dilated Cardiomyopathy. Annu Rev Med. 75:417–426. 2024.
View Article : Google Scholar :
|
|
135
|
Kadhi A, Mohammed F and Nemer G: The
Genetic Pathways Underlying Immunotherapy in Dilated
Cardiomyopathy. Front Cardiovasc Med. 8:6132952022. View Article : Google Scholar
|
|
136
|
Li D, Pi W, Sun Z, Liu X and Jiang J:
Ferroptosis and its role in cardiomyopathy. Biomed Pharmacother.
153:1132792022. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Al-Adhami A, Avtaar Singh SS, De SD, Singh
R, Panjrath G, Shah A, Dalzell JR, Schroder J and Al-Attar N:
Primary graft dysfunction after heart transplantation-unravelling
the enigma. Curr Probl Cardiol. 47:1009412022. View Article : Google Scholar
|
|
138
|
Gong CW, Yuan MM and Qiu BQ: Sterile
inflammation in thoracic transplantation. Molecular Cell.
78:581–601. 2021. View Article : Google Scholar
|
|
139
|
Li W, Feng G, Gauthier JM, Lokshina I,
Higashikubo R, Evans S, Liu X, Hassan A, Tanaka S, Cicka M, et al:
Ferroptotic cell death and TLR4/Trif signaling initiate neutrophil
recruitment after heart transplantation. J Clin Invest.
129:2293–2304. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Green DR: The coming decade of cell death
research: Five Riddles. Cell. 177:1094–1107. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Shi L, Liu Y, Li M and Luo Z: Emerging
roles of ferroptosis in the tumor immune landscape: from danger
signals to anti-tumor immunity. FEBS J. 289:3655–3665. 2022.
View Article : Google Scholar
|
|
142
|
Mallah SI, Atallah B, Moustafa F, Naguib
M, El Hajj S, Bader F and Mehra MR: Evidence-based pharmacotherapy
for prevention and management of cardiac allograft vasculopathy.
Prog Cardiovasc Dis. 63:194–209. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Jin JL, Zhang HW, Cao YX, Liu HH, Hua Q,
Li YF, Zhang Y, Wu NQ, Zhu CG, Xu RX, et al: Association of small
dense low-density lipoprotein with cardiovascular outcome in
patients with coronary artery disease and diabetes: A prospective,
observational cohort study. Cardiovasc Diabetol. 19:452020.
View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Li L, Wang H, Zhang J, Chen X, Zhang Z and
Li Q: Effect of endothelial progenitor cell-derived extracellular
vesicles on endothelial cell ferroptosis and atherosclerotic
vascular endothelial injury. Cell Death Discov. 7:2352021.
View Article : Google Scholar : PubMed/NCBI
|
|
145
|
McNerney ME, Lee KM, Zhou P, Molinero L,
Mashayekhi M, Guzior D, Sattar H, Kuppireddi S, Wang CR, Kumar V
and Alegre ML: Role of natural killer cell subsets in cardiac
allograft rejection. Am J Transplant. 6:505–513. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Wang W, Green M, Choi JE, Gijón M, Kennedy
PD, Johnson JK, Liao P, Lang X, Kryczek I, Sell A, et al: CD8+ T
cells regulate tumour ferroptosis during cancer immunotherapy.
Nature. 569:270–274. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Kinsella A, Rao V, Fan CP, Manlhiot C,
Stehlik J, Ross H and Alba AC: Post-transplant survival in adult
congenital heart disease patients as compared to dilated and
ischemic cardiomyopathy patients; an analysis of the thoracic ISHLT
registry. Clin Transplant. 34:2020. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Aldouri MA, Wonke B, Hoffbrand AV, Flynn
DM, Ward SE, Agnew JE and Hilson AJ: High incidence of
cardiomyopathy in beta-thalassaemia patients receiving regular
transfusion and iron chelation: Reversal by intensified chelation.
Acta Haematol. 84:113–117. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Liu P and Olivieri N: Iron overload
cardiomyopathies: New insights into an old disease. Cardiovasc Drug
Ther. 8:101–110. 1994. View Article : Google Scholar
|
|
150
|
Engle MA, M Erlandson M and Smith CH: Late
cardiac complications of chronic, severe, refractory anemia with
hemochromatosis. Circulation. 30:698–705. 1964. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Quinlan GJ, Evans TW and Gutteridge JM:
Iron and the redox status of the lungs. Free Radic Biol Med.
33:1306–1313. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Shvartsman M, Fibach E and Cabantchik ZI:
Transferrin-iron routing to the cytosol and mitochondria as studied
by live and real-time fluorescence. Biochem J. 429:185–193. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Oudit GY, Sun H, Trivieri MG, Koch SE,
Dawood F, Ackerley C, Yazdanpanah M, Wilson GJ, Schwartz A, Liu PP
and Backx PH: L-type Ca2+ channels provide a major pathway for iron
entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med.
9:1187–1194. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
154
|
Tsushima RG, Wickenden AD, Bouchard RA,
Oudit GY, Liu PP and Backx PH: Modulation of iron uptake in heart
by L-Type Ca2+ channel modifiers. Circ Res.
84:1302–1309. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Das SK, Patel VB, Basu R, Wang W,
DesAulniers J, Kassiri Z and Oudit GY: Females are protected from
iron-overload cardiomyopathy independent of iron metabolism: Key
role of oxidative stress. J Am Heart Assoc. 6:e0034562017.
View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Brewer C, Otto-Duessel M, Wood RI and Wood
JC: Sex differences and steroid modulation of cardiac iron in a
mouse model of iron overload. Transl Res. 163:151–159. 2014.
View Article : Google Scholar :
|
|
157
|
Zhang H, Zhabyeyev P, Wang S and Oudit GY:
Role of iron metabolism in heart failure: From iron deficiency to
iron overload. Biochim Biophys Acta Mol Basis Dis. 1865:1925–1937.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Zhao X, Si L, Bian J, Pan C, Guo W, Qin P,
Zhu W, Xia Y, Zhang Q and Wei K: Adipose tissue macrophage-derived
exosomes induce ferroptosis via glutathione synthesis inhibition by
targeting SLC7A11 in obesity-induced cardiac injury. Free Radic
Biol Med. 182:232–245. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Nguyen NT, Nguyen TT, Da Ly D, Xia JB, Qi
XF, Lee IK, Cha SK and Park KS: Oxidative stress by Ca2+
overload is critical for phosphate-induced vascular calcification.
Am J Physiol Heart Circ Physiol. 319:H1302–H1312. 2020. View Article : Google Scholar
|
|
160
|
Akahori H, Tsujino T, Naito Y, Matsumoto
M, Lee-Kawabata M, Ohyanagi M, Mitsuno M, Miyamoto Y, Daimon T, Hao
H, et al: Intraleaflet haemorrhage is associated with rapid
progression of degenerative aortic valve stenosis. Eur Heart J.
32:888–896. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Laguna-Fernandez A, Carracedo M, Jeanson
G, Nagy E, Eriksson P, Caligiuri G, Franco-Cereceda A and Bäck M:
Iron alters valvular interstitial cell function and is associated
with calcification in aortic stenosis. Eur Heart J. 37:3532–3535.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Morvan M, Arangalage D, Franck G, Perez F,
Cattan-Levy L, Codogno I, Jacob-Lenet MP, Deschildre C, Choqueux C,
Even G, et al: Relationship of iron deposition to calcium
deposition in human aortic valve leaflets. J Am Coll Cardiol.
73:1043–1054. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Xu Y, Lin H, Wang H, Pang J and Zhou Y:
Fraxetin attenuates ferroptosis in myocardial infarction via
AKT/Nrf2/HO-1 signaling. Am J Transl Res. 13:10315–10327.
2021.PubMed/NCBI
|
|
164
|
Liberman M, Bassi E, Martinatti MK, Lario
FC, Wosniak J Jr, Pomerantzeff PM and Laurindo FR: Oxidant
generation predominates around calcifying foci and enhances
progression of aortic valve calcification. Arterioscler Thromb Vasc
Biol. 28:463–470. 2008. View Article : Google Scholar
|
|
165
|
Schnabel RB, Yin X, Gona P, Larson MG,
Beiser AS, McManus DD, Newton-Cheh C, Lubitz SA, Magnani JW,
Ellinor PT, et al: 50 year trends in atrial fibrillation
prevalence, incidence, risk factors, and mortality in the
Framingham Heart Study: A cohort study. Lancet. 386:154–156. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Dai C, Kong B, Qin T, Xiao Z, Fang J, Gong
Y, Zhu J, Liu Q, Fu H, Meng H, et al: Inhibition of ferroptosis
reduces susceptibility to frequent excessive alcohol
consumption-induced atrial fibrillation. Toxicology.
465:1530552022. View Article : Google Scholar
|
|
167
|
Rose RA, Sellan M, Simpson JA,
Izaddoustdar F, Cifelli C, Panama BK, Davis M, Zhao D, Markhani M,
Murphy GG, et al: Iron overload decreases CaV1.3-dependent L-type
Ca2+ currents leading to bradycardia, altered electrical
conduction, and atrial fibrillation. Circ Arrhythm Electrophysiol.
4:733–742. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Fang J, Kong B, Shuai W, Xiao Z, Dai C,
Qin T, Gong Y, Zhu J, Liu Q and Huang H: Ferroportin-mediated
ferroptosis involved in new-onset atrial fibrillation with
LPS-induced endotoxemia. Front Pharmacol. 913:1746222021.
|
|
169
|
Liu D, Yang M, Yao Y, He S, Wang Y, Cao Z,
Chen H, Fu Y, Liu H and Zhao Q: Cardiac fibroblasts promote
ferroptosis in atrial fibrillation by secreting Exo-miR-23a-3p
Targeting SLC7A11. Oxid Med Cell Longev.
2022:39614952022.PubMed/NCBI
|
|
170
|
Russo V, Rago A, Pannone B, Di Meo F, Papa
AA, Mayer MC, Spasiano A, Russo MG, Golino P, Calabrò R and Nigro
G: Early electrocardiographic evaluation of atrial fibrillation
risk in beta-thalassemia major patients. Int J Hematol. 93:446–451.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Lee AS, Jung YJ, Thanh TN, Lee S, Kim W,
Kang KP and Park SK: Paricalcitol attenuates
lipopolysaccharide-induced myocardial inflammation by regulating
the NF-κB signaling pathway. Int J Mol Med. 37:1023–1029. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Li N, Wang W, Zhou H, Wu Q, Duan M, Liu C,
Wu H, Deng W, Shen D and Tang Q: Ferritinophagy-mediated
ferroptosis is involved in sepsis-induced cardiac injury. Free
Radic Biol Med. 160:303–318. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Calne DB and Calne JS: Normality and
Disease. Can J Neurol Sci. 15:3–4. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Kung YA, Chiang HJ and Li ML: Fatal
lymphocytic cardiac damage in coronavirus disease 2019 (COVID-19):
Autopsy reveals a ferroptosis signature. Clin Transplant.
130:113–117. 1990.
|
|
175
|
Wang YD, Liu ZJ, Ren J and Xiang MX:
Pharmacological Therapy of Abdominal Aortic Aneurysm: An Update.
Curr Vasc Pharmacol. 16:114–124. 2018. View Article : Google Scholar
|
|
176
|
Wang K, Song Y, Li H, Song J and Wang S:
Identification of differentially expressed ferroptosis-related
genes in abdominal aortic aneurysm: Bioinformatics analysis. Front
Cardiovasc Med. 9:9916132022. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Golledge J: Abdominal aortic aneurysm:
Update on pathogenesis and medical treatments. Nat Rev Cardiol.
16:225–242. 2019. View Article : Google Scholar
|
|
178
|
Quintana RA and Taylor WR: Cellular
Mechanisms of Aortic Aneurysm Formation. Circ Res. 124:607–618.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Sampilvanjil A, Karasawa T, Yamada N,
Komada T, Higashi T, Baatarjav C, Watanabe S, Kamata R, Ohno N and
Takahashi M: Cigarette smoke extract induces ferroptosis in
vascular smooth muscle cells. Am J Physiol Heart Circ Physiol.
318:H508–H518. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Chen L, Liu Y, Wang Z, Zhang L, Xu Y, Li
Y, Zhang L, Wang G, Yang S and Xue G: Mesenchymal stem cell-derived
extracellular vesicles protect against abdominal aortic aneurysm
formation by inhibiting NET-induced ferroptosis. Exp Mol Med.
55:939–951. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Zhuang J, Zhu H, Cheng Z, Hu X, Yu X, Li
J, Liu H, Tang P, Zhang Y, Xiong X and Deng H: PCSK9, a novel
immune and ferroptosis related gene in abdominal aortic aneurysm
neck. Sci Rep. 13:60542023. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Li N, Yi X, He Y, Huo B, Chen Y, Zhang Z,
Wang Q, Li Y, Zhong X, Li R, et al: Targeting ferroptosis as a
novel approach to alleviate aortic dissection. Int J Biol.
18:4118–4134. 2022. View Article : Google Scholar
|
|
183
|
Shi H, Wei J and He C: Where, When, and
How: Context-Dependent Functions of RNA Methylation Writers,
Readers, and Erasers. Mol Cell. 74:640–650. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Chen Y, Yi X, Huo B, He Y, Guo X, Zhang Z,
Zhong X, Feng X, Fang ZM, Zhu XH, et al: BRD4770 functions as a
novel ferroptosis inhibitor to protect against aortic dissection.
Pharmacol Res. 177:1061222022. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Kobashigawa J, Zuckermann A, Macdonald P,
Leprince P, Esmailian F, Luu M, Mancini D, Patel J, Razi R,
Reichenspurner H, et al: Report from a consensus conference on
primary graft dysfunction after cardiac transplantation. J Heart
Lung Transplant. 33:327–340. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Lund LH, Edwards LB, Kucheryavaya AY,
Dipchand AI, Benden C, Christie JD, Dobbels F, Kirk R, Rahmel AO,
Yusen RD, et al: The Registry of the International Society for
Heart and Lung Transplantation: Thirtieth Official Adult Heart
Transplant Report-2013; Focus Theme: Age. J Heart Lung Transplant.
32:951–964. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Bai T, Li M, Liu Y, Qiao Z and Wang Z:
Inhibition of ferroptosis alleviates atherosclerosis through
attenuating lipid peroxidation and endothelial dysfunction in mouse
aortic endothelial cell. Free Radic Biol Med. 160:92–102. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Neufeld EJ: Oral chelators deferasirox and
deferiprone for transfusional iron overload in thalassemia major:
New data, new questions. Blood. 107:3436–3441. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Philipp S, Cui L, Ludolph B, Kelm M,
Schulz R, Cohen MV and Downey JM: Desferoxamine and
ethyl-3,4-dihydroxybenzoate protect myocardium by activating NOS
and generating mitochondrial ROS. Am J Physiol Heart Circ Physiol.
290:H450–H457. 2006. View Article : Google Scholar
|
|
190
|
Duffy SJ, Biegelsen ES, Holbrook M,
Russell JD, Gokce N, Keaney JF Jr and Vita JA: Iron chelation
improves endothelial function in patients with coronary artery
disease. Circulation. 103:2799–2804. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Wong CAC and Leitch HA: Delayed time from
RBC transfusion dependence to first cardiac event in lower IPSS
risk MDS patients receiving iron chelation therapy. Leuk Res.
83:1061702019. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Paraskevaidis IA, Iliodromitis EK,
Vlahakos D, Tsiapras DP, Nikolaidis A, Marathias A, Michalis A and
Kremastinos DT: Deferoxamine infusion during coronary artery bypass
grafting ameliorates lipid peroxidation and protects the myocardium
against reperfusion injury: Immediate and long-term significance.
Eur Heart J. 26:263–270. 2005. View Article : Google Scholar
|
|
193
|
Tadokoro T, Ikeda M, Ide T, Deguchi H,
Ikeda S, Okabe K, Ishikita A, Matsushima S, Koumura T, Yamada KI,
et al: Mitochondria-dependent ferroptosis plays a pivotal role in
doxorubicin cardiotoxicity. JCI Insight. 5:e1327472020. View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Zilka O, Shah R, Li B, Friedmann Angeli
JP, Griesser M, Conrad M and Pratt DA: On the Mechanism of
Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the role of
lipid peroxidation in ferroptotic cell death. ACS Cent Sci.
3:232–243. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Yang WS, Kim KJ, Gaschler MM, Patel M,
Shchepinov MS and Stockwell BR: Peroxidation of polyunsaturated
fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci
USA. 113:E4966–E4975. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
196
|
Watanabe Y and Tatsuno I: Prevention of
cardiovascular events with omega-3 polyunsaturated fatty acids and
the mechanism involved. J Atheroscler Thromb. 27:183–198. 2020.
View Article : Google Scholar :
|
|
197
|
Bibli SI, Hu J, Leisegang MS, Wittig J,
Zukunft S, Kapasakalidi A, Fisslthaler B, Tsilimigras D, Zografos
G, Filis K, et al: Shear stress regulates cystathionine γ lyase
expression to preserve endothelial redox balance and reduce
membrane lipid peroxidation. Redox Biol. 28:1013792020. View Article : Google Scholar
|
|
198
|
Chakraborty A, Li Y, Zhang C, Li Y,
LeMaire SA and Shen YH: Simvastatin Ameliorates Diabetic
Cardiomyopathy by Attenuating Oxidative Stress and Inflammation in
Rats. Progress in Cardiovascular Diseases. 84:113–117. 1990.
|
|
199
|
Bai YT, Chang R, Wang H, Xiao FJ, Ge RL
and Wang LS: ENPP2 protects cardiomyocytes from erastin-induced
ferroptosis. Biochem Biophys Res Commun. 499:44–51. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Prasad A, Andrews NP, Padder FA, Husain M
and Quyyumi AA: Glutathione reverses endothelial dysfunction and
improves nitric oxide bioavailability. J Am Coll Cardiol.
34:507–514. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Imai H, Matsuoka M, Kumagai T, Sakamoto T
and Koumura T: Lipid peroxidation-dependent cell death regulated by
GPx4 and ferroptosis. Curr Top Microbiol Immunol. 403:143–170.
2017.PubMed/NCBI
|
|
202
|
Hinman A, Holst CR, Latham JC, Bruegger
JJ, Ulas G, McCusker KP, Amagata A, Davis D, Hoff KG, Kahn-Kirby
AH, et al: Vitamin E hydroquinone is an endogenous regulator of
ferroptosis via redox control of 15-lipoxygenase. PLoS One.
13:e02013692018. View Article : Google Scholar : PubMed/NCBI
|
|
203
|
Upston JM, Kritharides L and Stocker R:
The role of vitamin E in atherosclerosis. Prog Lipid Res.
42:405–422. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
204
|
Steinberg D: Is there a potential
therapeutic role for vitamin E or other antioxidants in
atherosclerosis? Curr Opin Lipidol. 11:603–607. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
205
|
Cogny A, Paul JL, Soni T, Atger V and
Moatti N: Vitamin E: Metabolism and role in atherosclerosis. Ann
Biol Clin (Paris). 52:515–522. 1994.
|
|
206
|
Dludla PV, Dias SC, Obonye N, Johnson R,
Louw J and Nkambule BB: A Systematic Review on the Protective
Effect of N-Acetyl Cysteine Against Diabetes-Associated
Cardiovascular Complications. Am J Cardiovasc Drugs. 18:283–298.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
207
|
Bartekova M, Barancik M, Ferenczyova K and
Dhalla NS: Beneficial Effects of N-acetylcysteine and
N-mercaptopropionylglycine on ischemia reperfusion injury in the
heart. Curr Med Chem. 25:355–366. 2018. View Article : Google Scholar
|
|
208
|
Badgley MA, Kremer DM, Maurer HC,
DelGiorno KE, Lee HJ, Purohit V, Sagalovskiy IR, Ma A, Kapilian J,
Firl CEM, et al: Cysteine depletion induces pancreatic tumor
ferroptosis in mice. Science. 368:85–89. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
209
|
Wang C, Zhu L, Yuan W, Sun L, Xia Z, Zhang
Z and Yao W: Diabetes aggravates myocardial ischaemia reperfusion
injury via activating Nox2-related programmed cell death in an
AMPK-dependent manner. J Cell Mol Med. 24:6670–6679. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
210
|
Xiao Z, Kong B, Fang J, Qin T, Dai C,
Shuai W and Huang H: Ferrostatin-1 alleviates
lipopolysaccharide-induced cardiac dysfunction. Bioengineered.
12:9367–9376. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
211
|
Feng Y, Madungwe NB, Imam Aliagan AD,
Tombo N and Bopassa JC: Liproxstatin-1 protects the mouse
myocardium against ischemia/reperfusion injury by decreasing VDAC1
levels and restoring GPX4 levels. Biochem Biophys Res Commun.
520:606–611. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
212
|
Fang X, Wang H and Han D: Traditional
Chinese medicine for cardiovascular disease. Proc Natl Acad Sci
USA. 12:9367–9376. 2021.
|
|
213
|
Li W, Feng G and Gauthier JM: Translating
traditional herbal formulas into modern drugs: a network-based
analysis of Xiaoyao decoction. Cell Death Differ.
119:1183562020.
|
|
214
|
Ferrara PE, Codazza S, Cerulli S, Maccauro
G, Ferriero G and Ronconi G: Physical modalities for the
conservative treatment of wrist and hand's tenosynovitis: A
systematic review. Semin Arthritis Rheum. 50:1280–1290. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
215
|
Wang R, Wang M, Zhou J, Wu D, Ye J, Sun G
and Sun X: Saponins in Chinese Herbal Medicine Exerts Protection in
Myocardial Ischemia-Reperfusion Injury: Possible mechanism and
target analysis. Front Pharmacol. 11:5708672021. View Article : Google Scholar : PubMed/NCBI
|
|
216
|
Chen GQ, Benthani FA, Wu J, Liang D, Bian
ZX and Jiang X: Artemisinin compounds sensitize cancer cells to
ferroptosis by regulating iron homeostasis. Cell Death Differ.
27:242–254. 2020. View Article : Google Scholar :
|
|
217
|
Wang S, Liu W, Wang J and Bai X:
Curculigoside inhibits ferroptosis in ulcerative colitis through
the induction of GPX4. Life Sci. 259:1183562020. View Article : Google Scholar : PubMed/NCBI
|
|
218
|
Zhu K, Zhu X, Liu S, Yu J, Wu S and Hei M:
Glycyrrhizin attenuates hypoxic-ischemic brain damage by inhibiting
ferroptosis and neuroinflammation in neonatal rats via the
HMGB1/GPX4 Pathway. Oxid Med Cell Longev. 2022:84385282022.
View Article : Google Scholar : PubMed/NCBI
|
|
219
|
Fan Z, Cai L, Wang S, Wang J and Chen B:
Baicalin prevents myocardial ischemia/reperfusion injury through
inhibiting ACSL4 mediated ferroptosis. Front Pharmacol.
12:6289882021. View Article : Google Scholar : PubMed/NCBI
|
|
220
|
Zeng X, Li J and Li Z: Ginsenoside Rd
mitigates myocardial ischemia-reperfusion injury via Nrf2/HO-1
signaling pathway. Int J Clin Exp Med. 8:14497–14504.
2015.PubMed/NCBI
|
|
221
|
Wang D, Chen T and Liu F: Betulinic acid
alleviates myocardial hypoxia/reoxygenation injury via inducing
Nrf2/HO-1 and inhibiting p38 and JNK pathways. Eur J Pharmacol.
838:53–59. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
222
|
Li T, Tan Y, Ouyang S, He J and Liu L:
Resveratrol protects against myocardial ischemia-reperfusion injury
via attenuating ferroptosis. Gene. 808:1459682022. View Article : Google Scholar
|
|
223
|
Cao H, Wang P, Li N, Liu D, Ma J, Fan R
and Zhou Z: Practice of Comparative Effectiveness Research to
Identify Treatment Characteristics of Similar Chinese Patent
Medicine for Angina Pectoris. Evid Based Complement Alternat Med.
2017:70627142017. View Article : Google Scholar : PubMed/NCBI
|
|
224
|
Wu L, Fan Z, Gu L, Liu J, Cui Z, Yu B, Kou
J and Li F: QiShenYiQi dripping pill alleviates myocardial
ischemia-induced ferroptosis via improving mitochondrial dynamical
homeostasis and biogenesis. J Ethnopharmacol. 308:1162822023.
View Article : Google Scholar : PubMed/NCBI
|
|
225
|
Xu S, Wu B, Zhong B, Lin L, Ding Y, Jin X,
Huang Z, Lin M, Wu H and Xu D: Naringenin alleviates myocardial
ischemia/reperfusion injury by regulating the nuclear
factor-erythroid factor 2-related factor 2 (Nrf2)/System
xc-/glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis.
Bioengineered. 12:10924–10934. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
226
|
Zhao L, Shi H, Zhang F, Xue H and Han Q:
Hederagenin protects against myocardial ischemia-reperfusion injury
via attenuating ALOX5-mediated ferroptosis. Naunyn-Schmiedeberg's
Arch Pharmacol. 397:3411–3424. 2024. View Article : Google Scholar
|
|
227
|
D'Onofrio N, Servillo L and Balestrieri
ML: SIRT1 and SIRT6 signaling pathways in cardiovascular disease
protection. Antioxid Redox Signal. 28:711–732. 2018. View Article : Google Scholar :
|
|
228
|
Kane AE and Sinclair DA: Sirtuins and
NAD(+)in the development and treatment of metabolic and
cardiovascular diseases. Circ Res. 123:868–885. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
229
|
Li D, Liu X, Pi W, Zhang Y, Yu L, Xu C,
Sun Z and Jiang J: Fisetin Attenuates doxorubicin-induced
cardiomyopathy in vivo and in vitro by inhibiting ferroptosis
through SIRT1/Nrf2 signaling pathway activation. Front Pharmacol.
12:8084802022. View Article : Google Scholar : PubMed/NCBI
|
|
230
|
Wu S, Zhu J, Wu G, Hu Z, Ying P, Bao Z,
Ding Z and Tan X: 6-Gingerol alleviates ferroptosis and
inflammation of diabetic cardiomyopathy via the Nrf2/HO-1 pathway.
Oxid Med Cell Longev. Dec 31–2022.Epub ahead of print. View Article : Google Scholar
|
|
231
|
Zhou YX, Zhang H and Peng C: Puerarin: A
Review of Pharmacological Effects. Phytother Res. 28:961–975. 2014.
View Article : Google Scholar
|
|
232
|
Liu B, Zhao C, Li H, Chen X, Ding Y and Xu
S: Puerarin protects against heart failure induced by pressure
overload through mitigation of ferroptosis. Biochem Biophys Res
Commun. 497:233–240. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
233
|
Zhang D, Zhang Y, Gao Y, Chai X, Pi R,
Chan G and Hu Y: Current understanding of iron homeostasis. Gene.
106:1559S–1566S. 2017.
|
|
234
|
Fang X, An P, Wang H, Wang X, Shen X, Li
X, Min J, Liu S and Wang F: Dietary intake of heme iron and risk of
cardiovascular disease: A dose-response meta-analysis of
prospective cohort studies. Nutr Metab Cardiovasc Dis. 25:24–35.
2015. View Article : Google Scholar
|
|
235
|
Han M, Guan L and Ren Y: Physical
modalities for the conservative treatment of wrist and hand's
tenosynovitis: A systematic review. Asia Pac J Clin Nutr.
29:309–321. 2020.
|
|
236
|
Zhao L, Shi H and Zhang F: Deficiency in
Beclin1 attenuates alcohol-induced cardiac dysfunction via
inhibition of ferroptosis. Front Pharmacol. 2021:1–15. 2021.
|
|
237
|
Bao X, Luo X, Bai X, Lv Y, Weng X, Zhang
S, Leng Y, Huang J, Dai X, Wang Y, et al: Cigarette tar mediates
macrophage ferroptosis in atherosclerosis through the
hepcidin/FPN/SLC7A11 signaling pathway. Free Radic Biol Med.
201:76–88. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
238
|
Violi F, Nocella C, Loffredo L, Carnevale
R and Pignatelli P: Interventional study with vitamin E in
cardiovascular disease and meta-analysis. Free Radic Biol Med.
178:26–41. 2022. View Article : Google Scholar
|
|
239
|
Tang LJ, Zhou YJ, Xiong XM, Li NS, Zhang
JJ, Luo XJ and Peng J: Ubiquitin-specific protease 7 promotes
ferroptosis via activation of the p53/TfR1 pathway in the rat
hearts after ischemia/reperfusion. Free Radic Biol Med.
162:339–352. 2021. View Article : Google Scholar
|
|
240
|
Wang C, Yuan W, Hu A, Lin J, Xia Z, Yang
CF, Li Y and Zhang Z: Dexmedetomidine alleviated sepsis-induced
myocardial ferroptosis and septic heart injury. Mol Med Rep.
22:175–184. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
241
|
Ning D, Yang X, Wang T, Jiang Q, Yu J and
Wang D: Atorvastatin treatment ameliorates cardiac function and
remodeling induced by isoproterenol attack through mitigation of
ferroptosis. Biochem Biophys Res Commun. 574:39–47. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
242
|
Mishima E, Sato E, Ito J, Yamada KI,
Suzuki C, Oikawa Y, Matsuhashi T, Kikuchi K, Toyohara T, Suzuki T,
et al: Drugs repurposed as antiferroptosis agents suppress organ
damage, including AKI, by functioning as lipid peroxyl radical
scavengers. J Am Soc Nephrol. 31:280–296. 2020. View Article : Google Scholar :
|
|
243
|
Conlon M, Poltorack CD, Forcina GC,
Armenta DA, Mallais M, Perez MA, Wells A, Kahanu A, Magtanong L,
Watts JL, et al: A compendium of kinetic modulatory profiles
identifies ferroptosis regulators. Nat Chem Biol. 17:665–674. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
244
|
Oettl K, Greilberger J, Zangger K,
Haslinger E, Reibnegger G and Jürgens G: Radical-scavenging and
iron-chelating properties of carvedilol, an antihypertensive drug
with antioxidative activity. Biochem Pharmacol. 62:241–248. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
245
|
Hong M, Rong J, Tao X and Xu Y: The
emerging role of ferroptosis in cardiovascular diseases. Front
Pharmacol. 13:8220832022. View Article : Google Scholar : PubMed/NCBI
|
|
246
|
Fang W, Xie S and Deng W: Ferroptosis
mechanisms and regulations in cardiovascular diseases in the past,
present, and future. Cell Biol Toxicol. 40:172024. View Article : Google Scholar : PubMed/NCBI
|
